Company / Income Tax per Share
BioMarin Pharmaceutical Income Tax per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.69
FY2025
5-year range
-$0.06 / $0.69
FY2021-FY2025
Trend
+15.3%
vs FY2024
Sector context
#25 of 201
Health Care
What the data says
BioMarin Pharmaceutical's income tax per share of $0.69 is higher than 88% of companies in the Health Care sector (FY2025). Income Tax per Share has increased for 5 consecutive years, from $-4.97 in FY2020 to $0.69 in FY2025.
Based on SEC 10-K filings.
0.69 in FY2025 with a 3-year CAGR of +152.7%. Top quartile in the Health Care sector.
Increased from $0.11 to $0.69 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- +152.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
-48.5% below sector average
Key checks
Key Insights
- BioMarin Pharmaceutical's income tax per share has grown for 5 consecutive years.
- In FY2025, income tax per share increased 15.3% year-over-year.
- Ranks #25 out of 201 companies in the Health Care sector.
- Lowest income tax per share in the period was in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.69 | +15.3% |
| FY2024 | $0.60 | +443.1% |
| FY2023 | $0.11 | +157.7% |
| FY2022 | $0.04 | +169.4% |
| FY2021 | -$0.06 | +98.8% |
| FY2020 | -$4.97 | -1159.2% |
| FY2019 | -$0.39 | -7.4% |
| FY2018 | -$0.37 | -179.6% |
| FY2017 | $0.46 | +139.7% |
| FY2016 | -$1.16 | -1200.5% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026